Cellectis

CLLS NASDAQ Santé & Biotech France US15117K1034
3.09 $
0.08 %

Cellectis est une entreprise biopharmaceutique spécialisée dans l'ingénierie des cellules CAR-T pour le traitement des cancers.

Performance & Momentum

6 Months 24.63 %
1 Year 141.10 %
3 Years 85.26 %
5 Years 75.79 %

Similar stocks to Cellectis

Anantys Community

Be the first to share your analysis on Cellectis.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases